3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
31
Carcinoma, Intraductal, Noninfiltrating
3
Ovarian Neoplasms
2
Neoplasms
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunctions, Psychological
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Locoregional Recurrence
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Granulosa cell tumor of the ovary
1
Endometrial Neoplasms
1
Carcinoma, Ductal
1
Breast Carcinoma In Situ
1
Anatomic Stage III Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Advanced Breast Cancer
1
Acrocephalosyndactylia
1
Interventions
Specimen Handling
6
Tamoxifen
4
ruxolitinib
1
pembrolizumab
1
exemestane
1
Watchful Waiting
1
Surveys and Questionnaires
1
Starch
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Radiation
1
Protons
1
Proton Therapy
1
Omacor
1
Observation
1
Methods
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Laser Therapy
1
Interviews as Topic
1
Hypnosis, Anesthetic
1
Genotype
1
Educational Status
1
Early Intervention, Educational
1
Decision Support Techniques
1
Counseling
1
Cannabidiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Carcinoma In Situ
×
exemestane
×
90 days
×
Clear all
NCT06671912
2026-06-02
LoTam
Alliance for Clinical Trials in Oncology
Phase 3
Suspended
1,156 enrolled